Tianmu Pharmaceutical announced that the controlling shareholder Huilong Huaze holds 29.99% of the company's shares and plans to transfer 24.355,800 shares of the company's unlimited tradable shares through a public solicitation agreement with the transferee, accounting for 20% of the company's total share capital. The current public offering transfer price is not less than 22 yuan/share. If the implementation of this public collection and transfer is completed, the controlling shareholders and actual controllers of the company may change.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.